News

A new study published by CIMTEC client Proteocyte provides further data showing Straticyte offers better predictive insight over...

TORONTO, ON − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the “Company” or “3DS”), is pleased to announce that the clinical trial...

Brings deep experience in medtech commercialization LONDON (August 8, 2017) – The Centre for Imaging Technology Commercialization (CIMTEC)...

TORONTO--(BUSINESS WIRE)--KalGene Pharmaceuticals Inc., in collaboration with the National Research Council of Canada (NRC), CIMTEC and the...

3D Signatures (TSX Venture: DXD.V; OTCQB: TDSGF; Frankfurt: 3DO) is a medical imaging company that is developing diagnostic tools based on...

CIMTEC

CIMTEC spin-off NeoVision was founded to commercialize the neonatal brain imaging technology derived from Dr. Aaron Fenster's research at...

OBI logo

UPDATE AS OF FRIDAY MARCH 17TH 4:00PM   IMPORTANT - DEADLINE EXTENDED TO TUESDAY MARCH 21ST!   2017 OBI ONtrepreneurs Program Application...

Ontario’s wealth of cancer research expertise is not limited to one city or region. Innovations from researchers and clinician-scientists...

TechAlliance

FedDev Ontario Invests $1.32 Million to Support 30 Companies and Create Jobs News Release From Federal Economic Development Agency for...

CIMTEC

CIMTEC is proud to take part in the official launch of our client Radialis Medical.  As part of Lakehead University’s Research and...

Pages